NCT06344637

Brief Summary

This randomized control trial aim to evaluate the effectiveness of local lidocaine spray application to the cervix on the reducing of pain score during the manual vacuum aspiration

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
216

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 14, 2023

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

February 28, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 3, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2024

Completed
Last Updated

April 3, 2024

Status Verified

March 1, 2024

Enrollment Period

6 months

First QC Date

February 28, 2024

Last Update Submit

March 30, 2024

Conditions

Keywords

manual vacuum aspirationpain scoreLidocaine spray

Outcome Measures

Primary Outcomes (2)

  • pain score during manual vauum aspiration

    The pain score using visual analog scale is used to assess the pain score during the manual vacuum aspiration during procedure (score 0-10), the 0 score is no pain and the 10 score is the maximum pain

    during surgery

  • pain score after manual vauum aspiration

    The pain score using visual analog scale is used to assess the pain score after the procedure (score 0-10) the 0 score is no pain and the 10 score is the maximum pain

    at 30 minutes postoperative

Study Arms (2)

10% lidocaine spray without adrenaline

EXPERIMENTAL

4 puffs of 10% lidocaine spray without adrenaline apply on cervical os before manual vacuum aspiration

Drug: 10 % lidocaine spray without adrenaline

Placebo

PLACEBO COMPARATOR

4 puffs of normal saline apply on cervical os before manual vacuum aspiration

Other: Placebo

Interventions

Pateint with indication for manual vacuum aspiration aged between 20-60 years will received a standard injection of pethidine along with 1% lidocaine spray without adrenaline on cervical os to compare pain scores with placebo. Along with measuring side effects immediately and 30 minutes after receiving 1% lidocaine without adrenaline.

Also known as: 10% Xylocaine spray
10% lidocaine spray without adrenaline
PlaceboOTHER

4 puffs of normal saline apply on cervical os before manual vacuum aspiration

Placebo

Eligibility Criteria

Age20 Years - 60 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • female ageed 20 years to 60 years who have an indication for manual vacuum adpiration under intraveneous analgesia

You may not qualify if:

  • patient with allergic to lidocaine or history of allergic to lidocaine
  • patient with reproductive and urinary infection
  • patient with abnormal vital sign
  • patient with abnormal kidney and liver function test

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UdonThani Hospital

Udon Thani, UdonThani, 41000, Thailand

Location

MeSH Terms

Conditions

Pain, Procedural

Interventions

Epinephrine

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

EthanolaminesAmino AlcoholsAlcoholsOrganic ChemicalsAminesBiogenic MonoaminesBiogenic AminesCatecholaminesCatecholsPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbons

Study Officials

  • PATTARIKAN MANAYING

    UdonThani Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

February 28, 2024

First Posted

April 3, 2024

Study Start

December 14, 2023

Primary Completion

May 30, 2024

Study Completion

July 30, 2024

Last Updated

April 3, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations